BRAF and colorectal cancer: Another case in point is a computational model of the MAPK signaling network developed by Kirouac et al. to predict the clinical outcomes of ERK inhibition in colorectal cancer with the BRAF-V600E mutation [78], in which the authors started from in vitro cell culture data to in vivo animal response to clinical prediction using one general model framework.